Administer: Sarastia remains key to growth revival - Evli
Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier.
Administer’s Q3 was soft, with lower net sales weighing on profitability. Cost-saving measures should support margins slightly in the short term, while the pending Sarastia acquisitions remain the key potential value driver.